The BRidge Towards Implementation of Blood-based Biomarkers to Enable Early and Accurate Diagnosis of Alzheimer's Disease
Abroad (travel likely)Recruiting
Conditions
Alzheimer Blood Biomarkers · Alzheimer's Disease (AD)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Amsterdam UMC, Amsterdam, North Holland, Netherlands
Contact: Principal Investigator (F H Duits, MD PhD)Jeroen Bosch Ziekenhuis, 's-Hertogenbosch, Netherlands
Contact: Principal Investigator (A van Strien, MD PhD)Flevoziekenhuis, Almere Stad, Netherlands
Contact: Principal Investigator (M I Kester, MD PhD)Spaarne Gasthuis, Haarlem, Netherlands
Contact: Study coordinator (N SM Schoonenboom, MD PhD) · schoonenboom@spaarnegasthuis.nl · 0031232240110Contact: Principal Investigator (N SM Schoonenboom, MD PhD)Tergooi MC, Hilversum, Netherlands
Contact: Principal Investigator (S S Staekenborg, MD PhD)Frisius MC, Leeuwarden, Netherlands
Contact: Principal Investigator (N A Verwey, MD PhD)Dijklander Ziekenhuis, Purmerend, Netherlands
Contact: Principal Investigator (L AR Zwart, MD PhD)Elisabeth-TweeSteden Ziekenhuis, Tilburg, Netherlands
Contact: Principal Investigator (H P Aben, MD PhD)